|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 405/12 | |
| A61K 31/517 | |||
| A61P 35/00 |
| (11) | Patento numeris | 3089976 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15700325.2 |
| Europos patento paraiškos padavimo data | 2015-01-02 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-11-09 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-08-14 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/010013 |
| Data | 2015-01-02 |
| (87) | Numeris | WO 2015/103456 |
| Data | 2015-07-09 |
| (30) | Numeris | Data | Šalis |
| 201461922982 P | 2014-01-02 | US | |
| 201461932317 P | 2014-01-28 | US | |
| 201462016155 P | 2014-06-24 | US |
| (72) |
TUSKAR, Mihaela, HR
RATKAJ, Marina, HR
ZEGARAC, Miroslav, HR
|
| (73) |
Teva Pharmaceuticals International GmbH,
Schlüsselstrasse 12, 8645 Jona,
CH
|
| (54) | CRYSTALLINE FORMS OF AFATINIB DIMALEATE |
| CRYSTALLINE FORMS OF AFATINIB DIMALEATE |